Atlas Trials

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Clinical trial NCT04861584 · RECRUITING

Trial details

NCT number
NCT04861584
Sponsor
Zhujiang Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Urinary Bladder Cancer
Start date
2021-06-03
Primary completion
2026-10-03
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.